Effect of O6-Benzylguanine Analogues on Sensitivity of Human Tumor Cells to the Cytotoxic Effects of Alkylating Agents

Cancer Research

Volumn 51, Issue 13, 1991, Pages 3367-3372

  Moschel, Robert C ^c   Pegg, Anthony E ^b  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 O BENZYLGUANINE; CARMUSTINE; CISPLATIN; DACARBAZINE; LOMUSTINE; STREPTOZOCIN; ALKYLATING AGENT; ANTINEOPLASTIC AGENT; CHLOROZOTOCIN; CYCLOPHOSPHAMIDE; DNA; DRUG DERIVATIVE; GUANINE; MESYLIC ACID DERIVATIVE; MESYLMESYLIC ACID 2 CHLOROETHYL ESTER; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; METHYLTRANSFERASE; O(6) BENZYLGUANINE; O(6) METHYLGUANINE DNA METHYLTRANSFERASE; O(6)-BENZYLGUANINE; PERFOSFAMIDE;

ARTICLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG INTERACTION; DRUG POTENTIATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR CELL LINE; CELL CULTURE; CELL SURVIVAL; CHEMISTRY; DNA DAMAGE; DRUG EFFECT; IN VITRO STUDY; METABOLISM;

ALKYLATING AGENTS; ANTINEOPLASTIC AGENTS; CARMUSTINE; CELL SURVIVAL; CISPLATIN; CYCLOPHOSPHAMIDE; DNA; DNA DAMAGE; DRUG SYNERGISM; GUANINE; HUMAN; IN VITRO; LOMUSTINE; MESYLATES; METHYLTRANSFERASES; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; STREPTOZOCIN; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR CELLS, CULTURED;

EID: 0025924488     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Colvin, M., and Chabner, B. A. Alkylating agents. In: B. A. Chabner and J. M. Collins (eds.). Cancer Chemotherapy: Principles and Practice, pp. 276-313. Philadelphia: J. B. Lippincott, 1990.
2. Gibson, N. W. Alkylating agents: mechanisms and modulation. In: F. M. Muggia (ed.). Cancer Chemotherapy: Concepts. Clinical Investigations and Therapeutic Advances, pp. 3-22. Boston: Kluwer, 1988.
3. McCormick, J. E., and McElhinney, R. S. Nitrosoureas from chemist to physician: classification and recent approaches to drug design. Eur. J. Cancer, 26:207-221, 1990.
4. Anderson T., McMenamin, M. G., and Schein, P. S. Chlorozotocin, 2-[3-(2-chloroethyl)-3-nitrosoureido]-D glucopyranose. An antitumor agent with modified bone marrow toxicity. Cancer Res., 35: 761, 1975.
5. Fox, P. A., Panasci, L. C., and Schein, P. S. Biological and biochemical properties of l-(2-chloroethyl)-3-(N-D-glucopyranosyl)-1-nitrosourea (NSC D 254157) a nitrosourea with reduced bone marrow toxicity. Cancer Res., 37: 783, 1977.
6. Gralla, R. J., Tan, C. T. C., and Young, C. W. Phase I trial of chlorozotocin. Cancer Treat. Rep., 63: 17-20, 1979.
7. Pegg, A. E. Mammalian 06-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents. Cancer Res., 50:6119-6129, 1990.
8. Waxman, D. J., Glutathione 5-transferases: role in alkylating agent resistance and possible target for modulation chemotherapy: a review. Cancer Res., 50: 6449-6454, 1990.
9. Woolley, P. V., and Tew, K. D. Mechanisms of Drug Resistance in Neoplastic Cells, pp. 1-390. San Diego: Academic Press, 1988.
10. Orren, D. K., and Sancar, A. New discoveries in the enzymology of DNA repair. Cancer Rev., 7: 5-27, 1987.
11. Yarosh, D. B. The role of 06-methylguanine-DNA methyltransferase in cell survival, mutagenesis and carcinogenesis. Mutat. Res., 145: 1-16, 1985.
12. Pegg, A. E., and Dolan, M. E. Properties and assay of mammalian Ob-alkylguanine-DNA alkyltransferase. Pharmacol. Ther., 34: 167-179, 1987.
13. Erickson, L. C., Laurent, G., Sharkey, N. A., and Kohn, K. W. DNA crosslinking and monoadduct repair in nitrosourea-treated human tumour cells. Nature (Lond.), 288: 727-729, 1980.
14. Dolan, M. E., Moschel, R. C., and Pegg, A. E. Depletion of mammalian (T6-alkylguanine-DNA alkyltransferase activity by (O-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents. Proc. Natl. Acad. Sci. USA, 87: 5368-5372, 1990.
15. Dolan, M. E., Stine, L., Mitchell, R. B., Moschel, R. C., and Pegg, A. E. Modulation of mammalian 06-alkylguanine-DNA alkyltransferase in vivo by O-benzylguanine and its effect on the sensitivity of a human glioma tumor to l-(2-chloroethvl)-3-(4-methvlcvclohexvl)-l-nitrosourea. Cancer Com-mun., 2: 371-377, 1990. '
16. Brookes, P., Dipple, A., and Lawley, P. D. The preparation and properties of some benzylated nucleosides. J. Chem. Soc., 2026-2028 (c), 1968.
17. 6-methylguanine on DNA interstrand cross-link formation by chloroethylnitro-soureas and 2-chloroethyl (methvlsulfonvl)methanesulfonate. Cancer Res., 48: 3603-3606, 1988.
18. Hansen. M. B., Nielsen, S. E., and Berg, K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods, 119: 203-210. 1989.
19. Domoradzki, J., Pegg, A. E., Dolan, M. E., Maher, V. M., and McCormick, J. J. Correlation between -methylguanine-DNA-methyltransferase activity and resistance of human cells to the cytotoxic and mutagenic effect of jY-methyl-A-nitro-N-nitrosoguanidine. Carcinogenesis (Lond.), 5: 1641-1647, 1984.
20. Dolan. M. E., Young. G. S., and Pegg, A. E. Effect of 06-alkylguanine pretreatment on the sensitivity of human colon tumor cells to the cytotoxic effects of chloroethylating agents. Cancer Res. 46: 4500-4504, 1986.
21. Bradford. M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principles of protein-dye binding. Anal. Biochem., 72: 248-254, 1976.
22. Gerson, S. L., Miller, K., and Berger. N. A. t-Alkylguanine-DNA alkyltransferase activity in myeloid cells. J. Clin. Invest., 76: 2106-2114, 1985.
23. Tong, VV. P., Kirk, M. C., and Ludlum. D. B. Formation of the cross-link 1-[/V'-deoxycytidyip-ljY'-deoxyguanosinyll-ethane in DNA treated with A\N'-bis(2-chloroethyl)-A'-nitrosourea. Cancer Res., 42: 3102-3105, 1982.
24. Ludlum, D. B. DNA alkylation by the haloethylnitrosoureas: nature of modifications produced and their enzvmatic repair or removal. Mutat. Res., 233: 117-126, 1990.
25. Brent, T. P. Isolation and purification of Oalkylguanine-DNA alkyltransferase from human leukemic cells. Prevention of chloroethylnitrosourea-induced cross-links bv purified enzyme. Pharmacol. Ther., 31: 121-140, 1985.
26. Robins, P., Harris. A. L., Goldsmith, I., and Lindahl. T. Cross-linking of DNA induced by chloroethvlnitrosourea is prevented by Omethylguanine-DNA methyltransferase. Nucleic Acids Res. II: 7743-7758, 1983.
27. Kohn, K. W. Interstrand cross-linking of DNA by l,3-bis(2-chloroethyl)-l-nitrosourea and other 1 -(2-haloethyl)-1 -nitrosoureas. Cancer Res., 37: 1450-1454, 1977. '
28. Brent, T. P., and Remack, J. S. Formation of covalent complexes between human {N-alkylguanine-DNA alkyltransferase and BC Nil-treated defined length synthetic oligodeoxvnucleotides. Nucleic Acids Res., 16: 6779-6788, 1988.
29. Black, D. J., and Livingston. R. B. Antineoplastic drugs in 1990-a review (Part 1). Drugs, 39: 489-501. 1990.
30. Schold. S. C., Jr., Brent, T. P., von Hofe, E., Friedman. H. S., Mitra, S., Bigner, D. D., Swenberg, J. A., and Kleihues, P. 06-alkylguanine-DNA alkyltransferase and sensitivity to procarbazine in human brain-tumor xenografts. J. Neurochem., 70: 573-577, 1989.
31. Hall, J., and Montesano, R. DNA alkylation damage: consequences and relevance to tumour production. Mutat. Res., 233: 247-252, 1990.
32. Maher, V. M., Domoradzki, J., Bhattacharyya. N. P., Tsujimura, T., Corner, R. C., and McCormick, J. J. Alkylation damage, DNA repair and mutagenesis in human cells. Mutat. Res., 233: 235-245, 1990.